These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 15885820)

  • 1. Behavioral assessment in mouse models of neuronal ceroid lipofuscinosis using a light-cued T-maze.
    Wendt KD; Lei B; Schachtman TR; Tullis GE; Ibe ME; Katz ML
    Behav Brain Res; 2005 Jun; 161(2):175-82. PubMed ID: 15885820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
    Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD
    Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of neuronal ceroid lipofuscinoses: useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics.
    Shacka JJ
    Brain Res Bull; 2012 May; 88(1):43-57. PubMed ID: 22502604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different early ER-stress responses in the CLN8(mnd) mouse model of neuronal ceroid lipofuscinosis.
    Galizzi G; Russo D; Deidda I; Cascio C; Passantino R; Guarneri R; Bigini P; Mennini T; Drago G; Guarneri P
    Neurosci Lett; 2011 Jan; 488(3):258-62. PubMed ID: 21094208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
    Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R
    J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular phenotype in a mouse gene knockout model for infantile neuronal ceroid lipofuscinosis.
    Lei B; Tullis GE; Kirk MD; Zhang K; Katz ML
    J Neurosci Res; 2006 Oct; 84(5):1139-49. PubMed ID: 16881055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging.
    Kopra O; Vesa J; von Schantz C; Manninen T; Minye H; Fabritius AL; Rapola J; van Diggelen OP; Saarela J; Jalanko A; Peltonen L
    Hum Mol Genet; 2004 Dec; 13(23):2893-906. PubMed ID: 15459177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells.
    Lonka L; Salonen T; Siintola E; Kopra O; Lehesjoki AE; Jalanko A
    J Neurosci Res; 2004 Jun; 76(6):862-71. PubMed ID: 15160397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.
    Ranta S; Zhang Y; Ross B; Lonka L; Takkunen E; Messer A; Sharp J; Wheeler R; Kusumi K; Mole S; Liu W; Soares MB; Bonaldo MF; Hirvasniemi A; de la Chapelle A; Gilliam TC; Lehesjoki AE
    Nat Genet; 1999 Oct; 23(2):233-6. PubMed ID: 10508524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
    Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
    J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice.
    Virmani T; Gupta P; Liu X; Kavalali ET; Hofmann SL
    Neurobiol Dis; 2005 Nov; 20(2):314-23. PubMed ID: 16242638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving towards therapies for juvenile Batten disease?
    Cooper JD
    Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of early postnatal retinal pathology in a mouse model of neuronal ceroid lipofuscinosis.
    Seigel GM; Wagner J; Wronska A; Campbell L; Ju W; Zhong N
    Eye (Lond); 2005 Dec; 19(12):1306-12. PubMed ID: 15565184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal degeneration in motor neuron degeneration: a mouse model of ceroid lipofuscinosis.
    Chang B; Bronson RT; Hawes NL; Roderick TH; Peng C; Hageman GS; Heckenlively JR
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1071-6. PubMed ID: 8125718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.
    Katz ML; Johnson GS; Tullis GE; Lei B
    Neurobiol Dis; 2008 Feb; 29(2):242-53. PubMed ID: 17962032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice.
    Kuronen M; Lehesjoki AE; Jalanko A; Cooper JD; Kopra O
    Neurobiol Dis; 2012 Sep; 47(3):444-57. PubMed ID: 22569358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An early-onset congenic strain of the motor neuron degeneration (mnd) mouse.
    Messer A; Manley K; Plummer JA
    Mol Genet Metab; 1999 Apr; 66(4):393-7. PubMed ID: 10191135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model for juvenile NCL: gene targeting of mouse Cln3.
    Greene ND; Bernard DL; Taschner PE; Lake BD; de Vos N; Breuning MH; Gardiner RM; Mole SE; Nussbaum RL; Mitchison HM
    Mol Genet Metab; 1999 Apr; 66(4):309-13. PubMed ID: 10191119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.